Page last updated: 2024-11-04

2-amino-3-ketobutyrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-amino-3-ketobutyrate: unstable intermediate in threonine dehydrogenase-initiated pathway for threonine utilization; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-amino-3-oxobutanoic acid : An alpha-amino acid that is acetoacetic acid which is substituted by an amino group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID219
CHEMBL ID1160073
CHEBI ID17844
SCHEMBL ID188494
MeSH IDM0213445

Synonyms (19)

Synonym
6531-42-6
2-amino-3-oxobutanoic acid
2-amino-3-ketobutyrate
CHEBI:17844 ,
2-amino-3-oxobutanoate
2-amino-acetoacetate
C03214
CHEMBL1160073
2-akbt
butanoic acid, 2-amino-3-oxo-
SCHEMBL188494
2-acetyl-amino-acetic acid
SAUCHDKDCUROAO-UHFFFAOYSA-N
DTXSID70983937
Q27102659
EN300-145187
CS-0312320
PD040704
2-amino-3-oxobutanoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
3-oxo monocarboxylic acid
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Glycine and Serine metabolism ( Glycine and Serine metabolism )3649
Acetyl-CoA + Glycine = CoA + L-2-Amino-3-oxo-butanoic acid ( Glycine and Serine metabolism )14

Bioassays (2)

Assay IDTitleYearJournalArticle
AID25427Half life at pH 5.92004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Biosynthesis of vitamin B6: direct identification of the product of the PdxA-catalyzed oxidation of 4-hydroxy-l-threonine-4-phosphate using electrospray ionization mass spectrometry.
AID25430Half life at pH 8.12004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Biosynthesis of vitamin B6: direct identification of the product of the PdxA-catalyzed oxidation of 4-hydroxy-l-threonine-4-phosphate using electrospray ionization mass spectrometry.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.05 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]